full-service outsourcing

R&D

Biotech and pharma companies increasingly require additional agility, flexibility, and operational efficiency in their clinical research operations.

News

MSD has signed a license agreement for a KRAS G12D inhibitor from China's SciBrunch, paying $400m upfront for the preclinical candidate.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.